V2 sact_drug_detail
7,662,029 rows · 7 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP |
|---|---|---|---|---|---|---|
| 10031517 | 10031785 | 65 | null | 1 | 2016-04-02 | PEMBROLIZUMAB |
| 10031518 | 10031786 | 0.5 | null | 2 | 2018-01-08 | TRIAL |
| 10031519 | 10031787 | null | null | 1 | 2020-04-09 | ATEZOLIZUMAB |
| 10031520 | 10031788 | 200 | null | 1 | 2021-07-20 | TAMOXIFEN |
| 10031521 | 10031789 | 120 | null | 2 | 2020-06-15 | AVELUMAB |
| 10031522 | 10031790 | 200 | null | 2 | 2020-10-15 | TRIAL |
| 10031523 | 10031791 | null | null | 2 | 2017-01-09 | PAZOPANIB |
| 10031524 | 10031792 | 1200 | X741 | 1 | 2019-09-06 | NIVOLUMAB |
| 10031525 | 10031793 | 160 | X729 | 1 | 2020-12-13 | ATEZOLIZUMAB |
| 10031527 | 10031795 | 0 | null | 2 | 2021-09-27 | ATEZOLIZUMAB |
| 10031529 | 10031797 | 480 | null | 2 | 2017-08-16 | TRIAL |
| 10031530 | 10031798 | 750 | null | 2 | 2018-04-10 | PAZOPANIB |
| 10031531 | 10031799 | 160 | null | 2 | 2018-08-29 | TRIAL |
| 10031532 | 10031800 | 600 | null | 2 | 2020-10-13 | NOT CHEMO |
| 10031534 | 10031802 | 138 | null | 5 | 2019-09-22 | ATEZOLIZUMAB |
| 10031536 | 10031804 | 20 | null | 2 | 2018-04-29 | NIVOLUMAB |
| 10031538 | 10031806 | 750 | X729 | 2 | 2022-05-05 | PEMBROLIZUMAB |
| 10031539 | 10031807 | 250 | X721 | 2 | 2019-07-25 | TRIAL |
| 10031540 | 10031808 | 300 | X721 | null | 2022-02-02 | TRIAL |
| 10031541 | 10031810 | 600 | null | 1 | 2019-05-07 | BCG |
| 10031542 | 10031811 | 200 | null | 1 | 2022-01-06 | TRIAL |
| 10031543 | 10031812 | 2.5 | null | 2 | 2019-10-09 | DOCETAXEL |
| 10031545 | 10031814 | null | null | 1 | 2021-10-10 | LENVATINIB |
| 10031546 | 10031815 | 0.3 | null | 5 | 2021-09-05 | DEXAMETHASONE |
| 10031547 | 10031816 | null | null | 2 | 2016-10-19 | TRIAL |
| 10031548 | 10031817 | null | null | 2 | 2019-09-23 | AZACITIDINE |
| 10031549 | 10031818 | 120 | null | 2 | 2021-02-18 | UMBRALISIB |
| 10031550 | 10031819 | null | null | 1 | 2021-03-08 | NIVOLUMAB |
| 10031551 | 10031820 | 600 | null | 2 | 2020-01-09 | TRIAL |
| 10031552 | 10031821 | 40 | null | 1 | 2022-04-07 | NIVOLUMAB |
| 10031553 | 10031822 | 0.3 | null | 2 | 2020-12-17 | TRIAL |
| 10031554 | 10031823 | 600 | null | 2 | 2021-01-25 | BORTEZOMIB |
| 10031555 | 10031824 | 40 | null | 2 | 2021-02-22 | PEMBROLIZUMAB |
| 10031556 | 10031825 | null | null | 1 | 2020-12-15 | BCG |
| 10031557 | 10031826 | 40 | null | 2 | 2021-04-30 | PEMBROLIZUMAB |
| 10031559 | 10031828 | 40 | null | 2 | 2022-02-25 | NOT CHEMO |
| 10031560 | 10031829 | 4.48 | null | 2 | 2021-11-10 | TRIAL |
| 10031561 | 10031830 | 240 | null | 1 | 2022-03-20 | IPILIMUMAB |
| 10031562 | 10031832 | 910 | null | 2 | 2021-02-22 | NIVOLUMAB |
| 10031563 | 10031833 | 930 | null | null | 2017-11-20 | VENETOCLAX |
| 10031564 | 10031834 | 65 | null | 1 | 2018-06-07 | DOCETAXEL |
| 10031565 | 10031835 | 100 | null | 2 | 2018-09-16 | TRIAL |
| 10031566 | 10031836 | 1 | null | 2 | 2017-09-06 | PAZOPANIB |
| 10031567 | 10031837 | 200 | null | 9 | 2019-07-27 | AVELUMAB |
| 10031568 | 10031838 | 250 | null | 5 | 2021-03-31 | AVELUMAB |
| 10031569 | 10031839 | 1200 | null | 1 | 2020-09-13 | PACLITAXEL |
| 10031570 | 10031840 | 420 | null | 2 | 2019-12-31 | TRIAL |
| 10031571 | 10031841 | 30 | null | 2 | 2022-01-22 | ZANUBRUTINIB |
| 10031572 | 10031842 | 1200 | null | 2 | 2020-11-15 | DOCETAXEL |
| 10031573 | 10031843 | 100 | null | 2 | 2021-06-07 | AVELUMAB |